170 related articles for article (PubMed ID: 7543503)
21. Histamine and tryptase in nasal lavage fluid after allergen challenge: effect of 1 week of pretreatment with intranasal azelastine or systemic cetirizine.
Jacobi HH; Skov PS; Poulsen LK; Malling HJ; Mygind N
J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):768-72. PubMed ID: 10329808
[TBL] [Abstract][Full Text] [Related]
22. Loss of size-selectivity at histamine-induced exudation of plasma proteins in atopic nasal airways.
Greiff L; Andersson M; Erjefält JS; Svensson C; Persson CG
Clin Physiol Funct Imaging; 2002 Jan; 22(1):28-31. PubMed ID: 12003096
[TBL] [Abstract][Full Text] [Related]
23. Tryptase in nasal lavage fluid after local allergen challenge. Relationship to histamine levels and TAME-esterase activity.
Juliusson S; Holmberg K; Baumgarten CR; Olsson M; Enander I; Pipkorn U
Allergy; 1991 Aug; 46(6):459-65. PubMed ID: 1957995
[TBL] [Abstract][Full Text] [Related]
24. Tryptase in nasal fluid is a useful marker of allergic rhinitis.
Rasp G; Hochstrasser K
Allergy; 1993 Feb; 48(2):72-4. PubMed ID: 8457035
[TBL] [Abstract][Full Text] [Related]
25. Effect of natural allergen exposure during the grass pollen season on airways inflammatory cells and asthma symptoms.
Djukanović R; Feather I; Gratziou C; Walls A; Peroni D; Bradding P; Judd M; Howarth PH; Holgate ST
Thorax; 1996 Jun; 51(6):575-81. PubMed ID: 8693436
[TBL] [Abstract][Full Text] [Related]
26. Nasal airway changes assessed by acoustic rhinometry and mediator release during immediate and late reactions to allergen challenge.
Zweiman B; Getsy J; Kalenian M; Lane A; Schwartz LB; Doty R; Lanza D
J Allergy Clin Immunol; 1997 Nov; 100(5):624-31. PubMed ID: 9389292
[TBL] [Abstract][Full Text] [Related]
27. Effects of two weeks of topical budesonide treatment on microvascular exudative responsiveness in healthy human nasal airways.
Greiff L; Andersson M; Svensson C; Akerlund A; Alkner U; Persson CG
Eur Respir J; 1997 Apr; 10(4):841-5. PubMed ID: 9150322
[TBL] [Abstract][Full Text] [Related]
28. Basophil and eosinophil accumulation and mast cell degranulation in the nasal mucosa of patients with hay fever after local allergen provocation.
KleinJan A; McEuen AR; Dijkstra MD; Buckley MG; Walls AF; Fokkens WJ
J Allergy Clin Immunol; 2000 Oct; 106(4):677-86. PubMed ID: 11031338
[TBL] [Abstract][Full Text] [Related]
29. [Humoral mucosal immunity in allergic rhinitis].
Kramer MF; Jordan TR; Pfrogner E; Rasp G
Laryngorhinootologie; 2005 Jul; 84(7):503-10. PubMed ID: 16010632
[TBL] [Abstract][Full Text] [Related]
30. Effects of fexofenadine on the early response to nasal allergen challenge.
Allocco FT; Votypka V; deTineo M; Naclerio RM; Baroody FM
Ann Allergy Asthma Immunol; 2002 Dec; 89(6):578-84. PubMed ID: 12487223
[TBL] [Abstract][Full Text] [Related]
31. Metachromatic, IgE-bearing and tryptase-containing cells on the nasal mucosal surface in provoked allergic rhinitis.
Juliusson S; Karlsson G; Bachert C; Enerbäck L
APMIS; 1994 Feb; 102(2):153-60. PubMed ID: 8167011
[TBL] [Abstract][Full Text] [Related]
32. The effect of short-term immunotherapy with molecular standardized grass and rye allergens on eosinophil cationic protein and tryptase in nasal secretions.
Klimek L; Wolf H; Mewes T; Dormann D; Reske-Kunz A; Schnitker J; Mann W
J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):47-53. PubMed ID: 9893184
[TBL] [Abstract][Full Text] [Related]
33. An in vitro model for measuring tryptase release from nasal mucosa in response to allergen challenge.
Mason JD; Smith SJ; Jones NS; Majumdar B; Read RC
Clin Otolaryngol Allied Sci; 1994 Oct; 19(5):407-9. PubMed ID: 7834882
[TBL] [Abstract][Full Text] [Related]
34. Hypertonic saline increases secretory and exudative responsiveness of human nasal airway in vivo.
Greiff L; Andersson M; Wollmer P; Persson CG
Eur Respir J; 2003 Feb; 21(2):308-12. PubMed ID: 12608446
[TBL] [Abstract][Full Text] [Related]
35. Immunotherapy and mast cell activation.
Carlos AG; Carlos ML; Santos MA; Pedro E; Santos S; Lopes-Pregal A
Allerg Immunol (Paris); 1998 Oct; 30(8):257-8. PubMed ID: 9846195
[TBL] [Abstract][Full Text] [Related]
36. Eosinophil cationic protein (ECP) and tryptase in the nasal lavage fluid (NLF) of children with grass pollen rhinitis: levocabastine effect.
Bernardini R; Novembre E; Mugnaini L; Rossi ME; Vierucci A
Allergy Asthma Proc; 1998; 19(2):75-80. PubMed ID: 9578915
[TBL] [Abstract][Full Text] [Related]
37. Tryptase inhibitors block allergen-induced airway and inflammatory responses in allergic sheep.
Clark JM; Abraham WM; Fishman CE; Forteza R; Ahmed A; Cortes A; Warne RL; Moore WR; Tanaka RD
Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):2076-83. PubMed ID: 8520778
[TBL] [Abstract][Full Text] [Related]
38. TNF alpha is localized to nasal mucosal mast cells and is released in acute allergic rhinitis.
Bradding P; Mediwake R; Feather IH; Madden J; Church MK; Holgate ST; Howarth PH
Clin Exp Allergy; 1995 May; 25(5):406-15. PubMed ID: 7553243
[TBL] [Abstract][Full Text] [Related]
39. Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol.
Swystun VA; Gordon JR; Davis EB; Zhang X; Cockcroft DW
J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):57-64. PubMed ID: 10887306
[TBL] [Abstract][Full Text] [Related]
40. Correlations between complaints, inflammatory cells and mediator concentrations in nasal secretions after nasal allergen challenge and during natural allergen exposure.
Wang D; Clement P; Smitz J; De Waele M; Derde MP
Int Arch Allergy Immunol; 1995 Mar; 106(3):278-85. PubMed ID: 7888790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
